99-8796. International Standard-Setting Activities; Codex Alimentarius Commission; Committee on Nutrition and Foods for Special Dietary Uses; Background Paper to Identify Perspectives and Issues Pertaining to International Guidelines on Vitamin and ...  

  • [Federal Register Volume 64, Number 68 (Friday, April 9, 1999)]
    [Notices]
    [Pages 17397-17399]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-8796]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 99N-0391]
    
    
    International Standard-Setting Activities; Codex Alimentarius 
    Commission; Committee on Nutrition and Foods for Special Dietary Uses; 
    Background Paper to Identify Perspectives and Issues Pertaining to 
    International Guidelines on Vitamin and Mineral Supplements
    
    AGENCY:  Food and Drug Administration, HHS.
    
    ACTION:  Notice; request for comments.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is asking interested 
    persons to submit comments that will be used by the U.S. delegate to 
    the Codex Committee on Nutrition and Foods for Special Dietary Uses 
    (CCNFSDU) to prepare a background paper to be considered by the CCNFSDU 
    prior to its considering the appropriateness of establishing guidelines 
    for vitamin and mineral supplements for the purposes of international 
    trade. The background paper will discuss the range of concerns and the 
    differences in rationales on this topic. The United States, which has 
    indicated its opposition to the development of such guidelines, has 
    been asked to participate in the development of this background paper 
    along with other governments. FDA is accepting this request in its role 
    as the agency representing the United States in the CCNFSDU.
    DATES:  Submit written comments by June 8, 1999.
    ADDRESSES: Submit written comments and recommendations to the Dockets 
    Management Branch (HFA-305), Food
    
    [[Page 17398]]
    
    and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 
    20852.
    
    FOR FURTHER INFORMATION CONTACT: Robert J. Moore, Center for Food 
    Safety and Applied Nutrition (HFS-456), Food and Drug Administration, 
    200 C St. SW., Washington, DC 20204, 202-205-4605.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Introduction
    
        The Codex Alimentarius Commission (Codex) is the joint food 
    standards program of the Food and Agriculture Organization of the 
    United Nations (FAO) and the World Health Organization (WHO). This 
    program was established in 1962 and develops food standards, codes of 
    practice, and other guidelines to help protect the health and economic 
    interests of consumers and to facilitate and encourage fair 
    international trade in food. The Codex accomplishes these actions 
    through the use of subordinate committees that develop food standards, 
    codes of practice, and other guidelines for consideration and adoption 
    by the Codex and member countries.
        In the United States, the U.S. Department of Agriculture (USDA), 
    FDA, and other agencies manage and carry out U.S. Codex activities. 
    Executive direction of this effort comes from the U.S. manager for 
    Codex, a responsibility of the Food Safety and Inspection Service 
    (FSIS) of USDA. For more information on U.S. Codex activities and the 
    responsibilities of the U.S. delegates to Codex committees, see the 
    Federal Registers of May 27, 1998 (63 FR 28966), and February 12, 1998 
    (63 FR 7118), respectively. Under section 491 of the Trade Agreements 
    Act of 1979 (19 U.S.C. 2578), as amended, and the Uruguay Round 
    Agreements Act, Pub. L. 103-465, 108 Stat. 4809, FSIS must inform the 
    public of the sanitary and phytosanitary standard setting activities of 
    international standard-setting organizations, such as Codex. The most 
    recent annual notice was published in the May 27, 1998, Federal 
    Register. That notice identified FDA as the responsible agency for the 
    United States with respect to the activities of the CCNFSDU (63 FR 
    28966 at 28973). Accordingly, the U.S. delegate to the CCNFSDU is from 
    FDA.
        This notice solicits information and comments relative to the 
    content of a background document that is intended to identify the 
    nature of and basis for differences in perspectives on establishing 
    guidelines for vitamin and mineral supplements in international trade. 
    This document is a component of the sanitary and phytosanitary 
    standard-setting activities of the CCNFSDU with regard to its 
    consideration of guidelines for vitamin and mineral supplements (Ref. 
    1).
    
    II. Background
    
        Germany proposed a process to consider the development of 
    guidelines for vitamin and mineral supplements at the October 1995 
    meeting of the CCNFSDU. Germany submitted the draft proposed guidelines 
    (Ref. 2), which were intended to address such issues as the composition 
    and labeling of vitamin and mineral supplements, including lists of 
    allowable vitamins and minerals and their sources, minimum and maximum 
    levels, permissible additives, packaging, labeling requirements, and 
    permissible claims. Codex circulated the proposal to member governments 
    for comment, and it was considered at the October 7 to 11, 1996, 
    CCNFSDU committee meeting (Ref. 3).
        At that meeting, the United States, through its delegate, indicated 
    its opposition to the development of the guidelines. Such guidelines 
    would not affect dietary supplements within the United States, whose 
    sale and marketing is regulated under the Federal Food, Drug, and 
    Cosmetic Act, as amended by the Dietary Supplement Health and Education 
    Act of 1994. However, such guidelines, were they developed and adopted 
    by other countries, could affect international trade in vitamin and 
    mineral supplements. In particular, such guidelines could have 
    ramifications for those U.S. manufacturers of dietary supplements that 
    export their products to countries that adopt such guidelines.
        CCNFSDU did not reach consensus on many aspects of the draft 
    proposed guidelines, but nonetheless, they forwarded the draft proposed 
    guidelines to Codex and recommended that the draft proposed guidelines 
    be advanced to the next level of consideration. Codex considered the 
    recommendation of the committee at its June 23 to 28, 1998, meeting in 
    Rome, Italy (Ref. 4). The United States, through its delegate, again 
    indicated its opposition to the advancement of the guidelines during 
    the Codex meeting.
        Codex did not advance the draft proposed guidelines to the next 
    level of consideration, but instead Codex returned them to the CCNFSDU 
    for further discussion and consideration. Codex also advised the 
    CCNFSDU to reconsider whether there was a need to proceed with the 
    development of the guidelines.
        The CCNFSDU considered the draft proposed guidelines again at its 
    September 21 to 25, 1998, meeting (Ref. 1). A copy of this document may 
    be downloaded from the internet at ``www.fao.org/es%2A/esn/codex/
    reports.htm''. The CCNFSDU discussed the draft proposed guidelines and 
    decided that while it was premature to stop work on the draft proposed 
    guidelines, there was not enough agreement to advance the proposed 
    draft guidelines for vitamin and mineral supplements to the next level 
    of consideration. Consequently, the draft proposed guidelines remained 
    at their current level of consideration. Because there was no consensus 
    on the need for the proposed guidelines or what they should contain, 
    the CCNFSDU decided that it would be useful to reconsider the basis for 
    continuing work on the draft proposed guidelines. The CCNFSDU believed 
    that it would facilitate its work if it could prepare a background 
    paper that would: (1) Provide ``a neutral and objective presentation on 
    the issues that should be considered on this subject'', (2) ``help 
    understand the rationale behind the different approaches'', and (3) 
    ``be useful to study in depth the principles justifying each particular 
    position in order to find a common ground for discussion'' (Ref. 1).
        The CCNFSDU chair asked the U.S. Government to contribute to this 
    background paper, which will be considered at the next meeting of the 
    CCNFSDU in the year 2000. The U.S. delegate agreed to this request. The 
    U.S. delegate concluded that there is value in assisting with the 
    development of an objective background paper that addresses the various 
    perspectives, approaches, and difficulties associated with developing 
    guidelines for international trade in vitamin and mineral supplements. 
    This activity is consistent with the U.S. interests in this matter and 
    will facilitate the decisionmaking process of the CCNFSDU.
    
    III. Request for Comments
    
        Interested persons may, on or before June 8, 1999, submit to the 
    Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 
    Fishers Lane, rm. 1061, Rockville, MD 20852, written comments regarding 
    this proposal. Two copies of any comments are to be submitted, except 
    that individuals may submit one copy. Comments are to be identified 
    with the docket number found in brackets in the heading of this 
    document. Received comments may be seen in the office above between 9 
    a.m. and 4 p.m., Monday through Friday.
        Based on the interest of the CCNFSDU in identifying the pros and 
    cons of developing guidelines for vitamin and mineral supplements and 
    in identifying
    
    [[Page 17399]]
    
    the various factors and principles pertaining to international 
    guidelines for vitamin and mineral supplements, FDA is asking for 
    comments that identify the range of perspectives associated with the 
    manufacture, use, and regulation of such products, as well as the 
    specific issues that the paper should address. Moreover, the CCNFSDU 
    intends to develop a paper that considers only issues relevant to 
    vitamin and mineral supplements. The CCNFSDU does not intend that the 
    paper will consider the addition of vitamins and minerals to 
    conventional foods nor products containing other ingredients or 
    substances, for example herbs or other botanicals. Accordingly, 
    comments on such matters will not assist the U.S. delegate to 
    contribute to the CCNFSDU paper.
        For the purposes of international trade, FDA has identified topics 
    that should be addressed in the background paper. The topics identified 
    for comment are as follows: (1) Topic 1 focuses on terminology, such as 
    the use of the terms ``food supplements'' or ``dietary supplements,'' 
    as compared to ``vitamin and mineral supplements;'' (2) topic 2 focuses 
    on the purpose and role of vitamin and mineral supplements; (3) topic 3 
    focuses on the concept of ``approved nutrients'' (i.e., a positive or 
    negative list of nutrients for use in the supplements of issue); (4) 
    topic 4 focuses on setting maximum levels for vitamins and minerals in 
    supplement form; (5) topic 5 focuses on setting minimal limits for 
    vitamins and minerals in such products; (6) topic 6 focuses on purity 
    and good manufacturing practices; (7) topic 7 focuses on labeling, 
    warning statements, and claims; and (8) topic 8 focuses on packaging 
    and marketing.
        For each topic, specific comments would be most helpful if they 
    addressed the following: (1) Is there a need for the topic? (2) What 
    are the various perspectives on the topic and what the difficulties in 
    addressing these perspectives? and (3) What are the options for making 
    decisions about the topic?
         We also welcome comments on the inclusion of additional topics. It 
    would be most helpful if the additional topic(s) could be addressed in 
    a fashion so as to respond to the three basic questions identified for 
    the other topics listed previously.
    
    IV. References
    
         The following references have been placed on display in the 
    Dockets Management Branch (address above) and may be seen by interested 
    persons between 9 a.m. and 4 p.m., Monday through Friday.
        1. Codex Alimentarius Commission, ``Report of the Twenty-First 
    Session of the Codex Committee on Nutrition and Foods for Special 
    Dietary Uses,'' ALINORM 99/26, FAO/WHO, Rome, 1998.
        2. Codex Alimentarius Commission, ``Report of the Twentieth 
    Session of the Codex Committee on Nutrition and Foods for Special 
    Dietary Uses,'' ALINORM 97/26, FAO/WHO, Rome, 1996.
        3. Codex Alimentarius Commission, ``Report of the Nineteenth 
    Session of the Codex Committee on Nutrition and Foods for Special 
    Dietary Uses,'' ALINORM 95/26, FAO/WHO, Rome, 1995.
        4. Codex Alimentarius Commission, ``Report of the Twenty-Second 
    Session of the Codex Alimentarius Commission,'' ALINORM 97/4, FAO/
    WHO, Rome, 1997.
    
        Dated: April 2, 1999.
    William K. Hubbard,
    Acting Deputy Commissioner for Policy.
    [FR Doc. 99-8796 Filed 4-8-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
04/09/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice; request for comments.
Document Number:
99-8796
Dates:
Submit written comments by June 8, 1999.
Pages:
17397-17399 (3 pages)
Docket Numbers:
Docket No. 99N-0391
PDF File:
99-8796.pdf